Join the club for FREE to access the whole archive and other member benefits.


Nanoparticle design platform to create evolving solutions for cancer treatment

We are a consortium of seven partners with the shared goal of creating an entirely new nanoparticle design platform capable of autonomously evolving solutions for cancer treatment. 

EVO-NANO brings together expertise in computer science, artificial evolution, modelling, microfluidics, and medicine.

We are a cross-disciplinary team working across Europe to produce targeted nanoparticles for the treatment of cancer tumours. Our scientists come from the University of Bristol and University of West of England, both in UK, University of Novi Sad, Serbia, Åbo Akademi University, Finland, IMDEA Software Institute, Vall d’Hebron Research Institute (VHIR), both in Spain, and ProChimia Surfaces in Poland.

Visit website:





EVONANO platform makes virtual tumour growth and drug design possible

University of Bristol - 22-Sep-2021

AI-powered software can be an alternative for expensive and extensive lab work


Technology to create virtual tumours and treat them with AI-designed nanoparticles

Nano Magazine - 22-Sep-2021

Virtual cancer tumours can be grown and we can design personalised nanoparticles to treat them